Recent reports revealed that forced expression of Grx3 in transgenic rat heart could enhance cardiomyocyte contractility by modulating calcineurin-NFAT-mediated signaling and PKCζ activity in the progression of pressure-overload induced heart hypertrophy 9-11. The gene discussed is GLRX3; the disease is cardiac hypertrophy.